BioMarin Pharmaceuticals
BMRN
BMRN
447 hedge funds and large institutions have $17.2B invested in BioMarin Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 65 funds opening new positions, 166 increasing their positions, 138 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
447
Holders Change
+18
Holders Change %
+4.2%
% of All Funds
10.25%
Holding in Top 10
12
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+33.33%
% of All Funds
0.28%
New
65
Increased
166
Reduced
138
Closed
45
Calls
$180M
Puts
$115M
Net Calls
+$64.8M
Net Calls Change
+$86.2M
Top Buyers
1 |
ClearBridge Investments
New York
|
+$212M |
2 |
Ameriprise
Minneapolis,
Minnesota
|
+$150M |
3 |
Viking Global Investors
Stamford,
Connecticut
|
+$149M |
4 |
SIG
Senator Investment Group
New York
|
+$94.2M |
5 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$48.4M |
Top Sellers
1 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
-$192M |
2 |
O
OppenheimerFunds
New York
|
-$102M |
3 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$83.8M |
4 |
Invesco
Atlanta,
Georgia
|
-$83.2M |
5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$58.5M |